Latest Trading Halts News

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

Big moves came from disclosure drama, CEO change news, and one standout software upgrade. While several stocks jumped on results, a few gaps couldn’t hold as traders sold into early strength.

Bubalus Resources has responded to ASX concerns over a delayed director interest notice, attributing the lapse to an administrative oversight and reaffirming its commitment to compliance.

Betmakers Technology Group has addressed an ASX price query following a surge in its share price linked to media reports of potential M&A interest from Tabcorp. The company confirms compliance with continuous disclosure rules and has authorised its response through its board.

Marmota Limited has raised $15 million through a well-supported placement, aiming to fast-track exploration at its promising Gawler gold project. The capital injection comes with strong institutional backing and sets the stage for upcoming drilling campaigns.

Cobre Limited has voluntarily suspended its ASX trading to finalise details of a significant acquisition and placement, with an announcement expected imminently.

Great Dirt Resources has raised $1.446 million through a discounted share placement and appointed seasoned resource executives to drive its growth strategy.

Revolution Private Credit Income Trust has successfully raised $60 million through a wholesale placement, strengthening its capacity to invest in senior secured loans and asset-backed securities across Australia and New Zealand.

EMC Gold has responded to an ASX price query following a sudden spike in its share price, confirming no undisclosed information exists and affirming compliance with continuous disclosure rules.

Island Pharmaceuticals has confirmed the material significance of recent FDA feedback on its Galidesivir development pathway and addressed ASX queries on disclosure timing and capital raising activities.

Tartana Minerals secures $4.5 million to ramp up exploration at its Nightflower Silver-Lead-Zinc-Antimony project and appoints a new director to bolster governance.

Revolution Private Credit Income Trust (REV) has announced a $60 million wholesale placement at $2.00 per unit, aiming to broaden its exposure to Australian and New Zealand private debt markets. The move is expected to enhance portfolio diversification and liquidity for unitholders.